Jazz Pharmaceuticals Plc Stock Market Value
| JAZZ Stock | USD 126.67 1.57 1.25% |
| Symbol | Jazz |
Jazz Pharmaceuticals PLC Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Jazz Pharmaceuticals. If investors know Jazz will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Jazz Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.597 | Earnings Share 7.06 | Revenue Per Share 64.039 | Quarterly Revenue Growth 0.085 | Return On Assets 0.0462 |
The market value of Jazz Pharmaceuticals PLC is measured differently than its book value, which is the value of Jazz that is recorded on the company's balance sheet. Investors also form their own opinion of Jazz Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Jazz Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Jazz Pharmaceuticals' market value can be influenced by many factors that don't directly affect Jazz Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Jazz Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Jazz Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Jazz Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Jazz Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Jazz Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Jazz Pharmaceuticals.
| 02/04/2023 |
| 11/25/2024 |
If you would invest 0.00 in Jazz Pharmaceuticals on February 4, 2023 and sell it all today you would earn a total of 0.00 from holding Jazz Pharmaceuticals PLC or generate 0.0% return on investment in Jazz Pharmaceuticals over 660 days. Jazz Pharmaceuticals is related to or competes with Incyte, Alnylam Pharmaceuticals, United Therapeutics, Ultragenyx, Apellis Pharmaceuticals, Biomarin Pharmaceutical, and Exelixis. Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products ... More
Jazz Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Jazz Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Jazz Pharmaceuticals PLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.87 | |||
| Information Ratio | 0.0206 | |||
| Maximum Drawdown | 10.09 | |||
| Value At Risk | (2.77) | |||
| Potential Upside | 3.8 |
Jazz Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jazz Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Jazz Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Jazz Pharmaceuticals historical prices to predict the future Jazz Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0716 | |||
| Jensen Alpha | 0.0533 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0223 | |||
| Treynor Ratio | 0.1797 |
Jazz Pharmaceuticals PLC Backtested Returns
At this stage we consider Jazz Stock to be very steady. Jazz Pharmaceuticals PLC holds Efficiency (Sharpe) Ratio of 0.0849, which attests that the entity had a 0.0849% return per unit of risk over the last 3 months. We have found thirty technical indicators for Jazz Pharmaceuticals PLC, which you can use to evaluate the volatility of the firm. Please check out Jazz Pharmaceuticals' Risk Adjusted Performance of 0.0716, downside deviation of 1.87, and Market Risk Adjusted Performance of 0.1897 to validate if the risk estimate we provide is consistent with the expected return of 0.17%. Jazz Pharmaceuticals has a performance score of 6 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.9, which attests to possible diversification benefits within a given portfolio. Jazz Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Jazz Pharmaceuticals is expected to follow. Jazz Pharmaceuticals PLC right now retains a risk of 2.05%. Please check out Jazz Pharmaceuticals treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to decide if Jazz Pharmaceuticals will be following its current trending patterns.
Auto-correlation | 0.44 |
Average predictability
Jazz Pharmaceuticals PLC has average predictability. Overlapping area represents the amount of predictability between Jazz Pharmaceuticals time series from 4th of February 2023 to 31st of December 2023 and 31st of December 2023 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Jazz Pharmaceuticals PLC price movement. The serial correlation of 0.44 indicates that just about 44.0% of current Jazz Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.44 | |
| Spearman Rank Test | 0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 48.76 |
Jazz Pharmaceuticals PLC lagged returns against current returns
Autocorrelation, which is Jazz Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Jazz Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Jazz Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Jazz Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Jazz Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Jazz Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Jazz Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Jazz Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Jazz Pharmaceuticals Lagged Returns
When evaluating Jazz Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Jazz Pharmaceuticals stock have on its future price. Jazz Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Jazz Pharmaceuticals autocorrelation shows the relationship between Jazz Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Jazz Pharmaceuticals PLC.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Jazz Stock Analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.